Concepedia
Statistics
Publications
1
Citations
10
H-Index
Active since
2023
Affiliations
Betta Pharmaceuticals (China)(Current)
Hongfei Rong is an author at Betta Pharmaceuticals (China).
Publications per year
2023–2023
Abstract 501: Discovery of BPI-460372, a potent and selective inhibitor of TEAD for the treatment of solid tumors harboring Hippo pathway aberrations
Hongling Shen, Xiaofeng Xu, Hongfei Rong et al. · Cancer Research · 2023 · 10 citations
1–1 of 1